1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Yifeng Pharmacy Chain Co., Ltd.
  6. Summary
    603939   CNE100001TS5

YIFENG PHARMACY CHAIN CO., LTD.

(603939)
  Report
End-of-day quote Shanghai Stock Exchange  -  05-19
42.79 CNY   -0.26%
05/19UBS Adjusts Yifeng Pharmacy Chain's Price Target to 60 Yuan From 86 Yuan, Keeps at Buy
MT
04/28Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
04/28Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
42.56 42.99 42.48 42.9 42.79 Last
4356944 3619531 3073323 2741009 2648702 Volume
+2.18% +1.01% -1.19% +0.99% -0.26% Change
Estimated financial data (e)
Sales 2022 18 900 M 2 824 M 2 824 M
Net income 2022 1 128 M 169 M 169 M
Net cash position 2022 1 690 M 252 M 252 M
P/E ratio 2022 27,1x
Yield 2022 0,83%
Sales 2023 23 581 M 3 523 M 3 523 M
Net income 2023 1 427 M 213 M 213 M
Net cash position 2023 1 979 M 296 M 296 M
P/E ratio 2023 21,5x
Yield 2023 1,08%
Capitalization 30 756 M 4 595 M 4 595 M
EV / Sales 2022 1,54x
EV / Sales 2023 1,22x
Nbr of Employees -
Free-Float 43,7%
More Financials
Company
Yifeng Pharmacy Chain Co., Ltd. is a China-based company principally engaged in the chain retailing of pharmaceuticals, health products, medical equipment and health-related household convenience products. The Company mainly operates through retailing segment. The Company operates more than 1, 000 direct pharmaceutical chain stores mainly in six provinces (or municipalities), including Hunan, Hubei, Shanghai,... 
Sector
Drug Retailers
Calendar
05/31 | 02:00amShareholder meeting
More about the company
Ratings of Yifeng Pharmacy Chain Co., Ltd.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D
More Ratings
All news about YIFENG PHARMACY CHAIN CO., LTD.
05/19UBS Adjusts Yifeng Pharmacy Chain's Price Target to 60 Yuan From 86 Yuan, Keeps at Buy
MT
04/28Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
04/28Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
2021Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2021Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Half Year Ended June 3..
CI
2021Ningbo Meishan Free Trade Zone Jikang Enterprise Management Partnership Enterprise (LP ..
CI
2021Shanghai Yifeng Pharmacy Chain Co., Ltd. announced that it expects to receive CNY 90 mi..
CI
2021Jiangsu Yifeng Pharmacy Chain Co., Ltd. announced that it expects to receive CNY 130 mi..
CI
2021Jiangxi Yifeng Pharmacy Chain Co., Ltd. announced that it expects to receive CNY 45 mil..
CI
2021Shanghai Yifeng Pharmacy Co., Ltd announced that it expects to receive CNY 90 million i..
CI
2021Jiangxi Yifeng Pharmaceutical Co., Ltd. announced that it expects to receive CNY 50 mil..
CI
2021Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the First Quarter Ended Ma..
CI
2021Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Full Year Ended Decemb..
CI
2020Yifeng Pharmacy Chain Co., Ltd. Reports Earnings Results for the Nine Months Ended Sept..
CI
2020YIFENG PHARMACY CHAIN CO., LTD.(XSSC : 603939) added to FTSE All-World Index
CI
More news
News in other languages on YIFENG PHARMACY CHAIN CO., LTD.
04/28Yifeng Pharmacy Chain Co., Ltd. annonce ses résultats pour le premier trimestre se term..
04/28Yifeng Pharmacy Chain Co., Ltd. annonce ses résultats pour l'année complète se terminan..
More news
Analyst Recommendations on YIFENG PHARMACY CHAIN CO., LTD.
More recommendations
Chart YIFENG PHARMACY CHAIN CO., LTD.
Duration : Period :
Yifeng Pharmacy Chain Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends YIFENG PHARMACY CHAIN CO., LTD.
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 42,79 CNY
Average target price 60,23 CNY
Spread / Average Target 40,8%
EPS Revisions
Managers and Directors
Yi Gao Chairman & Chief Executive Officer
Jian Qin Deng Chief Financial Officer
Bin Chen Chairman-Supervisory Board
En Bo Zhang Member-Supervisory Board
Lan Guang Yi Independent Director
Sector and Competitors